Bengaluru-Based Dozee Secures $8.3M Funding for Global Expansion & R&D
- Dozee has raised $6 million in Series A2 funding from investors including Prime Venture Partners, State Bank of India, and 3one4 Capital.
- The funds will be used to expand its presence in over 2,000 hospitals across 100 districts in India and accelerate global operations while enhancing R&D capabilities.
- The company plans further expansion into international markets like the US and UAE while aiming to transform critical care infrastructure globally.
Bengaluru-based healthtech startup Dozee has raised ₹71.5 crore ($8.3 million) in a mix of equity and debt funding to accelerate its global expansion and strengthen research and development (R&D) efforts.
The funding round included participation from Temasek Trust’s impact-first investment vehicle C3H, Stockhausen International Pte, and undisclosed strategic investors.
According to filings with the Ministry of Corporate Affairs (MCA), C3H contributed ₹6.3 crore as equity, while Stockhausen International infused ₹58.5 crore as debt. The remaining funds were secured from strategic investors whose identities remain undisclosed.
The company plans to utilize the fresh capital to enhance its critical patient monitoring systems and expand its international footprint.
Founded in 2015 by Mudit Dandwate and Gaurav Parchani, Dozee specializes in contactless remote patient monitoring solutions that track vital signs such as heart rate, respiration rate, blood pressure, and temperature.
Its AI-powered early warning system alerts healthcare professionals about potential health deterioration, enabling timely interventions.
Newsletter
The corridor, every morning.
Funding rounds and cross-border capital moves, one email, five minutes.
Dozee has already deployed its technology across hospitals in India and international markets like the US, UAE, and Africa. With this funding, the company aims to enter new global markets while diversifying its product portfolio.
The startup reported a 148% increase in revenue from operations in FY24, reaching ₹5.2 crore compared to ₹2.1 crore in FY23. Including other income, total revenue stood at ₹6.5 crore. The company also reduced its net loss by 19%, narrowing it to ₹68 crore from ₹84.4 crore the previous year. Total expenditure fell by 15% to ₹74.5 crore, with employee costs—the largest expense—declining by 12% to INR 47 crore.
Despite these improvements, Dozee laid off approximately 40 employees last year to curb losses but is optimistic about achieving profitability in India soon. The startup is actively hiring across departments such as data science, product development, and marketing.
Dozee competes with Indian healthtech startups like Zyla Health, Fix Health, Zivov, and Cardiac Design Labs. The startup previously raised ₹51.8 crore ($6 million) in a Series A2 funding round in April 2023 from Prime Venture Partners, YourNest VC, State Bank of India, and others. With the latest round, Dozee has raised nearly $20 million across multiple funding rounds.
Edited by Harshajit Sarmah
More in Funding
